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Purpose: Pterygium is a vision-impairing fibrovascular lesion that grows across the corneal surface and is associated with
sunlight exposure. To increase our understanding of the cells types involved in pterygium, we have used expressed
sequence tag analysis to examine the transcriptional repertoire of isolated pterygium and to identify marker genes for
tissue origin and cell migration.
Methods: An unnormalized unamplified cDNA library was prepared from 15 pooled specimens of surgically removed
pterygia as part of the NEIBank project. Gene expression patterns were compared with existing data for human cornea,
limbus, and conjunctiva, and expression of selected genes was verified by immunofluorescence localization in normal
eye ocular surface and in pterygium.
Results:  Sequence  analysis  of  2,976  randomly  selected  clones  produced  over  1,800  unique  clusters,  potentially
representing single genes. The most abundant complementary DNAs from pterygium include clusterin, keratins 13
(Krt13) and 4 (Krt4), S100A9/calgranulin B, and spermidine/spermine N1-acetyltransferase (SAT1). Markers for both
conjunctiva (such as keratin 13/4 and AQP3) and corneal epithelium (such as keratin 12/3 and AQP5) were present.
Immunofluorescence of Krt12 and 13 in the normal ocular surface showed specificity of Krt12 in cornea and Krt13 in
conjunctival and limbal epithelia, with a fairly sharp boundary at the limbal–corneal border. In the pterygium there was
a patchy distribution of both Krt12 and 13 up to a normal corneal epithelial region specific for Krt12. Immunoglobulins
were also among the prominently expressed transcripts. Several of the genes expressed most abundantly in excised
pterygium, particularly S100A9 and SAT1, have roles in cell migration. SAT1 exerts its effects through control of polyamine
levels. IPENSpm, a polyamine analogue, showed a significant ability to reduce migration in primary cultures of pterygium.
A number of genes highly expressed in cornea were not found in pterygium (several small leucine-rich proteoglycan
family members) or were expressed at considerably lower levels (ALDH3A1 and decorin).
Conclusions:  The  expression  pattern  of  keratins  and  other  markers  in  pterygium  most  closely  resemble  those  of
conjunctival and limbal cells; some corneal markers are present, notably Krt12, but at lower levels than equivalent
conjunctival markers. Our data are consistent with the model of pterygium developing from the migration of conjunctival-
and limbal-like cells into corneal epithelium. Identification of genes with roles in cell migration suggests potential
therapeutic targets. In particular, the ability of polyamine analogues to reduce migration in primary cultures of pterygium
presents a possible approach to slowing pterygium growth.
Pterygium is an overgrowth of fibrovascular tissue, often
with a wing-like appearance, from the conjunctiva over the
cornea [1-4]. It typically induces astigmatism [5,6], which can
be visually significant. Untreated it can invade the cornea,
occluding the pupil and leading to loss of vision. Pterygium
is common in many parts of the world and is particularly
prevalent in equatorial regions and high altitudes, implicating
UV exposure as a triggering insult. The principal treatment
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for pterygium is surgical removal. This approach can have
high success rates, but recurrence requiring repeat surgery and
complications  occur.  Conjunctival  autografts,  amniotic
membrane transplantation, and treatment with radiation or
chemotherapeutic  agents,  usually  mitomycin  C,  are  often
employed in attempts to reduce recurrence (for review, see
[7]). Pterygium pathophysiology is characterized by invasion
of  the  basement  membrane  of  normal  cornea  with  the
concomitant dissolution of Bowman’s layer [8]. In accordance
with this, pterygiuim cells show elevated expression of matrix
metalloproteinases (MMPs) [9].
Studies  aimed  at  characterization  of  the  molecular
composition of pterygium have been reported. Microarray
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2421comparisons  of  pterygium  and  conjunctiva-derived
fibroblasts found evidence for increased expression of insulin-
like growth factor-binding protein 2 in pterygium [2]. Another
microarray  study  compared  human  whole  pterygium  and
autologous  conjunctiva  and  found  increased  levels  of
extracellular-matrix-related,  proinflammatory,  angiogenic,
fibrogenic,  and  oncogenic  transcripts,  including  MMPs,
fibronectin, macrophage inflammatory protein 4 (MIP-4), and
lipocalin  2  in  pterygium  [10].  A  more  recent  microarray
analysis by Tong et al. [11] compared expression of primary
pterygia,  recurrent  pterygia,  and  uninvolved  conjunctiva.
Finding  increased  expression  of  adhesion  molecules  and
extracellular  matrix  and  structural  proteins  (fibronectin;
collagen and keratin family members), they concluded that
aberrant wound healing processes play a role in pterygium
pathogenesis.  Epithelial-mesenchymal  transition  (EMT),
with downregulation of E-cadherin and upregulation of β-
catenin  and  lymphoid-enhancer-factor-1,  has  also  been
proposed as a mechanism for the origin of pterygial fibroblasts
[1,12]. Pterygium has additionally been described as a benign
neoplastic lesion [9,13,14].
For  another  view  of  the  transcriptional  repertoire  of
pterygium,  we  have  used  expressed  sequence  tag  (EST)
analysis  of  an  unnormalized  unamplified  complementary
DNA  (cDNA)  library  made  from  pooled,  postmortem
pterygium through the NEIBank project for ocular genomics
[15,16].  The  results  show  abundant  expression  of
differentiated  markers  for  both  conjunctiva  and  corneal
epithelium, with conjunctival markers predominating. Other
abundant transcripts are associated with cell migration and
suggest new avenues for investigating possible therapeutic
approaches.
METHODS
Tissue  procurement  and  complementary  DNA  library
construction:  For  library  construction,  15  postmortem
pterygia were excised and immersed in RNAlater (Ambion,
Austin, TX). The procedure for obtaining the tissues was
within the tenets of the Declaration of Helsinki. Pterygia were
pooled and total RNA was extracted using RNAzol following
the  manufacturer’s  protocol  (Tel-Test  Inc.,  Friendswood,
TX). Total RNA (80 µg) was used for library construction.
Poly(A)+ RNA was prepared from the total RNA using
an oligo-dT cellulose affinity column (Invitrogen, Carlsbad,
CA). Oligo-dT-primed cDNA was synthesized at Bioserve
Biotechnology (Laurel, MD) using the Superscript II system
(Invitrogen, Carlsbad, CA), as described previously [17]. The
cDNA was run over a resin column (Sephacryl S-500 HR;
Invitrogen) to fractionate cDNA larger than 500 bp. The first
two  35-µl  fractions,  containing  cDNA,  were  pooled  and
directionally cloned in Not I/Sal I sites in the pCMVSPORT6
vector (Invitrogen) to make a cDNA library with internal
NEIBank  code  designation  nav.  The  library  consisted  of
approximately 107 primary recombinants. The average insert
size was estimated to be 1.63 kb; insert sizes ranged from 0.4
kb to 2.7 kb.
Complementary  DNA  sequencing  and  bioinformatics:
Approximately  3,000  clones  were  randomly  selected  and
sequenced from the 5' end at the National Institutes of Health
Intramural Sequencing Center. Grouping and identification of
sequence tags (GRIST) was used to analyze and assemble the
data  and  to  display  the  results  in  Web-page  format  [17].
Sequences were also examined using SeqMan II (DNAstar,
Madison, WI) to check assembly of clusters and to examine
alternative transcripts. Pterygium data were compared with
EST  data  for  other  relevant  datasets,  using  the  NEIBank
library comparison tool.
Pathway analysis: Pathway analysis was performed using the
software  provided  by  Ingenuity  Pathway  Analysis  (IPA;
Ingenuity,  Mountain  View,  CA).  Identifiers  for  genes
represented  by  three  or  more  clones  in  the  dataset  were
uploaded.  To  simplify  the  view,  genes  of  the  protein
translational machinery (ribosomal proteins, elongation, and
initiation  factors),  which  are  abundant  in  most  cDNA
libraries, were omitted. A network based upon the Ingenuity
pathways  knowledge  base  was  generated  by  connecting
protein  nodes  to  represent  direct  and  indirect  biological
relationships. Unconnected nodes were removed. Functional
analysis of the network was performed on 51 connected genes/
proteins.
Tissue collection and preparation for immunofluorescence:
Human eyes obtained from the Southern Eye Bank (Metairie,
LA) were treated according to the Helsinki Statement for the
Use  of  Human  Tissue.  Upon  arrival,  eyes  were  fixed  by
immersion in 4% paraformaldehyde in phosphate buffered
saline, pH 7.3, overnight and transferred to PBS. Anterior
segments  were  then  removed  to  separate  the  nasal  side
together with sclera, conjunctiva, cornea, and pterygia. The
tissue sections were oriented and embedded in Tissue-Tek
optimum  cutting  temperature  (OCT)  compound  (Sakura
Finetek U.S.A., Inc., Torrance, CA), stored at -70 ºC, and cut
into horizontal 10-µm-thick sections.
For  confocal  immunolocalization  studies,  5%  normal
serum was used as the blocking reagent for 30 min at 23 ºC,
followed by incubation for 1 h with the following primary
antibodies:  rabbit  anti-cytokeratin  13  (polyclonal,  1:50;
Protein Group, Inc., Chicago, IL), mouse anti-cytokeratin 12
(monoclonal,  1:25;  Biogenesis,  Poole,  UK),  mouse  anti-
human clusterin (monoclonal, 1:50; BD Bioscience, San Jose,
CA),  mouse  anti-S100A6  (calcyclin;  monoclonal  1:1,000;
Sigma®, Saint Louis, MO), mouse anti-SAT (spermidine/
spermine N1 acetyltransferase; polyclonal, 1:200), mouse-
anti-annexin II (3D5/4; monoclonal, 1:50; Gene-Tex Inc., San
Antonio, TX).
Sections were washed in immunolabeling buffer (PBS 1X
containing 0.5% bovine serum, 0.2% Tween-20, and 0.05%
sodium azide) then incubated for 30 min in the following
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mouse Alexa Fluor® 488, goat anti-rabbit Alexa Fluor® 568,
and 4',6-diamidino-2-phenylindole [DAPI; Molecular Probes,
Carlsbad,  CA]).  Primary  antibodies  were  omitted  from
sections used as negative controls. Sections of labeled human
anterior  segment  were  washed,  mounted  in  Gel-Mount
(Biomeda, Foster City, CA), and cover-slipped. A Leica SP2
confocal microscope (Leica Microsystems, Exton, PA) was
used to image samples.
Cell culture: Use of pterygium specimens was approved by
the  Institutional  Review  Board  of  Texas  Tech  School  of
Medicine,  Lubbock,  TX.  Specimens  were  handled  in
accordance with the Declaration of Helsinki. Pterygium were
collected at surgery, and the epithelium was separated from
the underlying stroma. The epithelial tissue was held in place
with a cover slip for 3 days in Dulbecco's Modified Eagle
Medium  Nutrient  Mixture  F-12  (DMEM/F12;  Invitrogen,
Carlsbad, CA) medium supplemented with 10% fetal calf
serum (FCS), 200 mM L-glutamine, 0.5% dimethyl sulfoxide
(DMSO), and 1% antibiotic/antimycotic, during which time
the cells migrated from the explant. The explant was then
removed and the medium changed to kerotinocyte- serum free
medium  with  5%  FCS  and  1%  antibiotic/antimycotic  to
further promote epithelial cell growth. When the cells were
60–80% confluent, they were passaged several times with
0.25% trypsin. The cells were then placed in DMEM/F12
medium supplemented with 5% fetal bovine serum, 1% L-
glutamine, 0.5% DMSO, and 1% antibiotic/antimycotic. The
medium was renewed every 2 to 3 days. Passage 5 cells were
used in our experimentation.
Cell migration assay: To analyze pterygium cell migration,
we used the CytoSelect 96-well cell migration assay (8 μm,
Fluorometric  Format;  Cell  Biolabs,  San  Diego,  CA),
following the manufacturer’s instructions. Briefly, feeder tray
wells were filled with 150 μl medium (±serum). Confluent
cells, grown to passage 5, were harvested; 100-μl aliquots of
serum-free  medium  containing  0.1–1.0×106  cells/ml  were
added to the wells of the membrane tray (upper tray) with or
without polyamine analogues. Migration assays were run for
18 h at 37 °C in a 5% CO2 incubator, after which medium was
removed from the membrane tray and the tray was placed over
a harvesting tray containing 150 μl of the proprietary cell
detachment solution for 30 min at 37 °C. The cells were treated
with fluorescent dye and measured at 480/520 nm using a
Victor3 multi-label reader (PerkinElmer, Shelton, CT). Initial
experiments showed that the extent of migration was directly
related to the amount of serum added to the bottom chamber
of the assay.
Polyamine analogues: Various concentrations (0–10 μM) of
N1,N11-diethylnorspermine  (BENSpm)  and  (S)-N1-(2-
methyl-1-butyl)-N11-ethyl-4,8-diazaundecane  (IPENSpm)
were  tested  in  the  migration  assay  by  including  various
concentrations  (0–10  μM)  in  the  wells  of  the  upper  tray.
Toxicity  of  the  compounds  at  10-μM  concentrations  was
checked  by  the  Cell  Counting  Kit-8  from  Dojindo
(Gaithersburg, MD).
RESULTS AND DISCUSSION
After  vector  trimming  and  removal  of  mitochondrial  and
contaminant sequences, almost 3,000 clones yielded 2,424
high-quality  sequence  reads  for  EST  analysis.  GRIST
assembled these clones into 1,832 unique clusters of which
87% consisted of single clones. Ninety clusters contained
three or more clones. Since this is an unnormalized library it
provides a view of the native abundance of transcripts in
pterygium. Table 1 lists the 25 most abundant transcripts (five
or more clones) and indicates those for which the literature
describes  preferential  expression  in  corneal  epithelium,
conjunctiva, or limbus. The entire dataset is available at the
NEIBank  website,  with  the  designation  NbLib0106  NEI
human pterygium unnormalized (nav).
Tissue  markers:  keratins:  The  most  abundant  tissue-
specificity marker cDNA in the library is Krt13, ranked in
abundance after eukaryotic translation elongation factor 1a1
and  clusterin,  which  are  highly  abundant  in  many  cDNA
libraries. Krt13, represented by 13 clones, is a marker for
conjunctiva [18,19] and has recently been shown to be highly
expressed in limbus [20]; its partner Krt4 (nine clones) is also
in the top seven transcripts. The equivalent keratin markers
for  corneal  epithelium  are  Krt12  and  Krt3  [21];  Krt12  is
present but at lower levels (four clones), while Krt3 does not
appear in the pterygium cDNA library. This is consistent with
the  microarray  analysis  by  Tong  et  al.  [11]  comparing
conjunctiva  and  pterygium,  which  likewise  shows  that
Krt13 levels are similar in conjunctiva and pterygium and that
Krt12 is present in pterygium but not in conjunctiva.
An overview of the relative abundance of all the keratin
transcripts in the pterygium library in comparison with the
human keratoconus (KC) cDNA library (NbLib0073) and
BodyMap cornea library (NbLib0077) is shown in Figure 1.
The human KC cDNA library provides a large set of cornea-
derived clones that correspond well with normal cornea [22]
and show the same general distribution of keratins found in
microarray  analysis  of  normal  human  cornea  [18].  The
pterygium library is represented by 2,298 clones, and there are
68,662 and 2,581 clones in the KC and BodyMap cornea
libraries,  respectively.  Data  from  the  only  available
conjunctiva  library  (BodyMap  unnormalized  human
conjunctiva epithelium NbLib0108) is not included since it
consists of fewer than 300 transcripts.
Krt19 is represented by nine clones, which includes a
sequence  from  the  3’-untranslated  region.  While  other
keratins are typically expressed as pairs (3/12; 4/13), Krt19
does  not  have  an  obligate  partner  [23,24];  it  is  found
particularly in the periderm, a transient superficial layer of
developing  epidermis  and  has  been  used  as  a  marker  for
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the KC library nor in the smaller sample of corneal epithelium
cells  [21],  suggesting  it  may  be  a  marker  for  pterygium.
However, microarray analysis revealed significant expression
of Krt19 in conjunctiva [18]. Interestingly, Krt19 has been
proposed as a marker for limbal stem cells [26,27].
Other  keratins  are  present  in  the  library  but  not
particularly abundant: the pair Krt14 and Krt5 both with three
clones, Krt15 with two clones, and Krt17 with one clone.
Although their representation here is small, it is interesting to
note the tissue distribution of these keratins as determined by
other  means.  Microarray  analysis  shows  Krt14/5  to  be
abundant  in  cornea  and  also,  but  to  a  lesser  extent,  in
conjunctiva [18], while Krt15 and Krt17 are fivefold and 10-
fold more abundant in conjunctiva, respectively. Krt 6 does
not appear in any of the human cDNA libraries, although
Krt6A  and  Krt6B  appear  to  be  upregulated  in  pterygium
relative  to  conjunctiva  in  microarray  analysis  [11].
Interestingly, there are 14 tags (1.3% of total) for Krt6 in the
NEI mouse cornea SAGE library NbLibo115 [28], suggesting
that expression of Krt6 in pterygium may occur at a low level
and might be more evident with SAGE analysis.
Immunofluorescence localization was used to examine
the distribution of Krt12 and 13 in the normal ocular surface
and in pterygium (Figure 2). Sections of normal human ocular
surface showed a clear demarcation of these two proteins, with
Krt12 staining throughout the corneal epithelium (with a fairly
sharp  transition  at  the  limbus)  and  Krt13  staining  in
conjunctival  and  limbal  epithelia  (Figure  2A).  A  similar
staining pattern for Krt13 was recently demonstrated by Ding
et al. [20], who also examined the ocular surface of a normal
human eye.
In the leading edge of the pterygium, there was mixed
Krt12  and  Krt13  staining  (Figure  2C),  with  some  cells
strongly positive for one or the other marker, suggestive of a
mixed population of corneal-, limbal-, and conjunctival-like
cells. While Krt12 is known to be highly expressed in cornea
[21], it is nevertheless relatively abundant in limbus according
to microarray, quantitative Reverse Transcription PCR, and
immunofluorecence studies in primates [20]. Therefore the
Krt12 staining in pterygium could equally well derive from
limbal  cells  in  the  leading  edge.  On  the  corneal  surface,
beyond  the  leading  edge  of  the  pterygium,  Krt13  is  not
detectable and the normal Krt12 staining is evident. This is
consistent with the EST analysis and suggests that much of
the pterygium is varied in nature and that pterygium may
spread across the corneal surface by migration of cells bearing
conjunctival and limbal markers into the corneal epithelium.
Other  conjunctiva/cornea  markers:  Aquaporins  also
show tissue-specific distribution in the ocular surface [29],
TABLE 1. THE 25 MOST ABUNDANTLY REPRESENTED GENES IN THE PTERYGIUM CDNA LIBRARY.
Rank Symbol Description Number of clones Conjunctiva Limbus Cornea
1 EEF1A1 eukaryotic translation elongation factor 1a1 22
2 CLU clusterin 14
3 KRT13 keratin 13 13 X X
4 IGKV1-5 kappaM immunoglobulin light chain 13
5 S100A9 S100 calcium binding protein A9 10
6 SAT1 spermidine/spermine N1-acetyltransferase 1 9
7 KRT4 keratin 4 9 X X
8 KRT19 keratin 19 8
9 UPLP Uroplakin-like protein 7
10 ANXA2 annexin A2 7
11 ALDH3A1 aldehyde dehydrogenase 3 A1 7 X
12 EIF4G2 eukaryotic translation initiation factor 4 gamma 2 6
13 PERP PERP, TP53 apoptosis effector 6
14 ACTG1 actin, gamma 1 5
15 EEF1G elongation factor 1-gamma 5
16 LGALS3 lectin, galactoside-binding, soluble, 3 5
17 RPL4 ribosomal protein L4 5
18 RPSA ribosomal protein SA 5
19 DCN decorin 5
20 FTH1 ferritin, heavy polypeptide 1 5
21 GNB2L1 guanine nucleotide binding protein beta2-like 1 5 X
22 AQP3 aquaporin 3 5
23 IGHG1 immunoglobulin heavy constant mu 5
24 DSP desmoplakin 5
25 TMSB4X thymosin, beta 4, X-linked 5
Genes are designated by Gene Symbols, followed by descriptions and the number of clones present in the library. Genes that
are known differential markers for conjunctiva, limbus, and cornea are indicated. Other genes, such as EEF1A1 and clusterin
are highly abundant in many cell types.
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cornea. In pterygium, AQP3, predominantly a conjunctival
marker,  is  represented  by  five  clones.  Indeed,  microarray
analysis does not indicate any differential expression between
conjunctiva and pterygium [11]. Abundant levels of AQP3
may impact cell migration of pterygium (see below). AQP5,
usually regarded as a corneal marker, is represented by three
clones.
Uroplakin 1b has been identified as a corneal epithelium
marker [21] and it is also abundant in KC [22] in cDNA library
analyses. In the pterygium dataset, uroplakin 1b is represented
by only one clone, while a different uroplakin-like protein
(UPLP)  gene,  similar  to  uroplakin  3b,  is  abundantly
represented (seven clones). Little is known about UPLP; the
gene for human UPLP overlaps with a larger gene described
as  DNA-directed  RNA  polymerase  II  polypeptide
(POLR2J2).  UPLP/POLR2J2  does  not  appear  in  cornea
libraries in the NEIBank from mouse, rabbit, or human nor
has it been observed in conjunctiva cDNAs [21] but may have
been  missed  in  a  small  sample  size.  However,  UPLP  is
abundantly expressed in KC, raising the possibility that it may
have  a  particular  role  in  ocular  surface  tissues  and  their
pathologies.
Transcripts  downregulated  in  pterygium  relative  to
cornea:  Several  genes  abundant  in  cornea-derived  cDNA
libraries are also abundant in pterygium but at lower levels
than in cornea. The cornea marker ALDH3A1 is found at a
frequency of 1.4% in KC; it is the ninth most abundant clone
in pterygium but it represents only 0.3% of the transcripts.
Similarly,  transforming  growth  factor  β-induced,  68  kDa
(TGFBI) accounts for 1.5% of clones in KC but only 0.13%
in pterygium, an order of magnitude difference. Dysregulation
of  TGFBI  expression  has  been  implicated  in  numerous
cancers,  with  effects  varying  according  to  cell  type  or
pathological  classification.  For  example,  TGFBI  is
upregulated  in  renal  clear  cell  carcinoma  [30],  while
downregulation of TGFBI is causally linked to tumorigenic
phenotype in both asbestos-treated [31] and radiation-exposed
bronchial epithelial cells [32]. Conversely, overexpression of
TGFBI demonstrated tumor suppressor activity in these cells
[33,34].  Knockout  of  TGFBI  in  mice  is  associated  with
spontaneous  tumor  development  [35].  Moreover,  genetic
studies have shown that missense mutations in this gene cause
various forms of corneal dystrophy [36,37]. Taken together,
these findings suggest that a certain minimum abundance of
functional or wild-type TGFBI is necessary for maintaining
normal corneal physiology. Transcripts for decorin are also
among the most abundant in the pterygium cDNA library, and
it, too, is reduced in relative abundance compared with KC; it
is at 1.5% in KC but only 0.2% in pterygium. Reduced decorin
expression  is  similarly  associated  with  tumorigenic
phenotypes  [38],  while  increased  levels  are  suppressive
[39-41]. As is the case with TGFBI, mutations in the decorin
gene are responsible for corneal dystrophy [42]. In cornea,
decorin has been shown to interact with TGFBI in complexes
that  in  turn  bind  collagen  type  VI  [43],  suggesting  these
Figure  1.  Abundance  of  different
keratins  in  pterygium,  cornea,  and
keratoconus  libraries.  The  relative
abundance of keratin transcripts in the
pterygium complementary DNA library
is compared to transcripts from cornea
(in the unnormalized BodyMap human
cornea NbLib0077) and keratoconus (in
unnormalized  human  keratoconus
cornea  NbLib0073).  The  contents  of
these  libraries  can  be  viewed  on  the
NEIBank website.
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2425proteins,  both  of  which  are  expressed  at  lower  levels  in
pterygium, work together in maintaining normal cornea.
Decreased  expression  of  decorin  is  paralleled  by
decreased  expression  of  several  closely  related  proteins.
Decorin is a member of the small leucine-rich proteoglycan
(SLRP) family of proteins. Other members of this family,
keratocan, lumican, and mimecan (also called osteoglycin) are
also highly expressed in cornea and are similarly thought to
contribute  to  corneal  transparency  [44-47].  In  an
unnormalized rabbit cornea library (NbLib0086), lumican,
keratocan, and osteoglycin account for 1.3, 1.3, and 1.4% of
transcripts, respectively. In contrast, there are no transcripts
for  any  of  these  SLRPs  in  the  pterygium  library.  It  is
interesting  that  the  SLRP  family  genes,  so  important  to
corneal  transparency,  are  collectively  downregulated  in
pterygium.
Other abundant transcripts: One of the most abundantly
expressed genes in pterygium (14 clones) is that encoding
clusterin, which is highly expressed in cornea and other ocular
tissues [21,22]. As implied by the existence of numerous other
names  (apolipoprotein  J,  testosterone-repressed  prostate
message 2, sulfated glycoprotein 2, complement-associated
protein SP-40), clusterin is a multifunctional protein whose
role in pterygium is open to speculation. Immunofluorescence
labeling  of  clusterin  in  pterygium  showed  an  interesting
pattern (Figure 3). There was intense staining for clusterin
throughout  the  fibrovascular  body  of  the  pterygium,  but
expression was much lower (or absent) in the outer layer of
cells, particularly at the leading edge. This suggests that the
pterygium body is enveloped by cells with a different gene
expression profile from the internal mass of cells.
Transcripts  from  the  immunoglobulin  κM  light-chain
locus (13 clones) on chromosome 2p11.2 are abundant in the
pterygium  dataset.  There  are  also  multiple  clones  for
immunoglobulin  μ  constant  regions.  This  suggests  the
presence  of  high  levels  of  immunoglobulin  M  (IgM)  in
pterygium  samples.  κM  chains  in  particular  have  been
associated with autoimmune reaction [48], while high overall
levels of IgM may reflect local reaction to a pathogen in one
or  more  of  the  pterygium  donors.  Interestingly,  IgM
transcripts are also abundant in human lacrimal gland [49],
suggesting that populations of IgM-expressing cells may be
commonly present at the ocular surface.
Although EMT has been implicated in the etiology of
pterygium  [1,12],  genes  specifically  annotated  with  EMT
associations in gene ontology [50] are not notably abundant
in the pterygium cDNA library. Those that are so annotated
are S100A4 (two clones), bone morphogenetic protein 7 (one
clone),  heterogeneous  nuclear  ribonucleoprotein  A/B  (one
clone), and alanine-glyoxylate aminotransferase 2-like 2 (one
clone).  One  gene  abundantly  expressed  in  pterygium,
LGALS3/galectin-3 (five clones), has been associated with
Figure  2.  Immunofluorescence  shows
the localization of keratin 12 and 13 in
normal ocular surface and pterygium.
Krt12 is labeled in red, Krt13 in green,
and nuclei are DAPI labeled in blue. A:
Krt12  and  Krt13  are  segregated  in
corneal  epithelium  and  conjunctival
epithelium  with  a  boundary  at  the
limbus:  Cj,  conjunctiva;  Lm,  limbus;
Ce,  corneal  epithelium.  B:  DAPI
staining of (A) indicates the nuclei of
conjunctiva, limbal region, and cornea.
C:  Corneal    epithelium  Ce,  is  Krt12
positive.    The  leading  edge  of  a
pterygium, Le, has mixed Krt12- and
Krt13-positive cells. D: DAPI stain of
(C) shows the nuclei of the leading edge
region and cornea.
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2426human fibrotic liver disease [51] and thus might play a similar
fibrosis-related  role  in  pterygium.  However  LGALS3/
galactin-3 is widely expressed and is found in ocular tissues
as  different  as  normal  lens  and  lacrimal  gland.  Although
MMPs have been shown to be upregulated in pterygium tissue
[10], they are not abundant enough to be represented in the
library.
Migration  markers:  In  addition  to  the  genes  that  are
markers  for  ocular  surface  cell  types,  pterygium  cDNA
analysis reveals several abundantly expressed genes that have
roles  in  cell  migration.  This  is  illustrated  by  the  network
shown in Figure 4. The network was generated using IPA to
draw connections between genes in the pterygium dataset
represented by three or more clones, based upon biological
relationships. Some major hubs are evident, most notably β2-
arrestin (ARRB2), c-Fos (FOS), β-actin (ACTB), and annexin
A2 (ANX2). Unconnected genes were removed from further
consideration. Functional analysis of the network showed that
29 of the 51 genes are associated with cell migration (p value
of 8.10E-20).
Figure 3. The abundance of clusterin in
pterygium  is  illustrated  by
immunofluorecence.  Labeling  for
clusterin  is  in  red,  nuclei  are  blue
(DAPI).  The  arrow  indicates  cells
enveloping the body of the pterygium
that are clusterin negative.
Figure 4. Network of abundant genes in
the  pterygium  cDNA  library  is
dominated  by  functional  associations
with  cell  migration  processes.  Genes
represented by three or more transcripts
in  the  pterygium  cDNA  library  were
analyzed  by  Ingenuity  Pathway
Analysis.  Each  gene  (node)  is
represented by a circle and labeled with
its  official  gene  symbol.  Direct  and
indirect relationships are indicated by
solid  and  dotted  lines,  respectively.
Arrows  indicate  the  direction  of
intermolecular action. Genes associated
with cell migration are shown in color.
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2427Notable among this class of migration-related transcrits
is  spermidine/spermine  N1-acetyltransferase  1  (SAT1),
represented by nine clones. SAT1 is a highly regulated rate-
limiting enzyme in polyamine metabolism [52] and as such
has roles in many cellular responses. Among these, and of
interest in pterygium, is integrin α9-dependent cell migration
[53]. Overexpression of SAT1 due to gene duplication has in
addition been implicated in keratosis follicularis spinulosa
decalvans [54], a disease that includes corneal degeneration.
Among many other functions, SAT1 has been shown to be
involved in the oxygen-independent degradation of hypoxia-
inducible factor 1α (HIF-1α) through interaction with both
HIF-1α and RACK1/guanine nucleotide-binding protein β2-
like 1 (GNB2L1) [55]. Interestingly, RACK1/GNB2L1 also
appears in the list of most abundant pterygium cDNAs (Table
1), so the potential for SAT1/GNB2L1 complex formation
exists.
The distribution of SAT1 in normal cornea and pterygium
was examined by immunofluorescence (Figure 5). Staining
for SAT1 was weak or absent in normal corneal epithelium
and limbus but, consistent with its cDNA abundance, was
detectable  throughout  the  body  of  the  pterygium.  Some
Figure  5.  Immunofluorescence
indicates  that  SAT1  expression  is
associated  with  the  leading  edge  and
body  of  pterygium.  SAT1
immunofluorescence (IF) is shown in
red and nuclei are DAPI labeled in blue.
CE, corneal epithelium; Pt, pterygium;
Cj, conjunctiva. A:  SAT1 is detectable
throughout the body of the pterygium
with a strongly labeled clump of cells at
the leading edge. B: Magnified view is
presented of the clump of cells strongly
positive  for  SAT1  at  the  apex  of  the
pterygium  body.  C:  No  SAT1  IF  is
apparent in limbus and normal cornea
from  the  other  side  of  the  same  eye
(section torn in corneal stroma).
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2428intensely staining groups of cells were observed, particularly
at the leading edge of the pterygium body (Figure 5B).
Annexin A2, a network hub in Figure 4, is represented by
seven clones in the pterygium collection. It is a calcium-
dependent membrane-binding protein that is implicated in
endocytosis [56] and also in epithelial cell migration [57].
Interestingly, annexin A2 has been shown to play a role in the
induction of MMP-9 activity [58], a hallmark of pterygial cell
migration [9]. Annexin A2 can form heterotetramers with the
small  calcium-binding  protein  p11/S100A10  [56],  but  no
clones for S100A10 are present among those sequenced from
the pterygium library. However, a different member of the
S100  family,  S100A9  (also  known  as  calgranulin  B  or
MRP14) is abundant in pterygium and is represented by10
clones. S100A9 is not known to be abundant in cornea and is
absent from the KC cDNA collection. SA100A9 is implicated
in inflammation and is upregulated in psoriasis [59]. It may
also be involved in control of cell migration since antibodies
to  S100A9  block  migration  of  tumor  cells  [60].  Other
members of the S100 family, A4, A6, A8, A11, and A14, are
also  represented  in  the  pterygium  cDNA  library.
Immunofluorescence using antibodies for A9 (Figure 6A–C)
and  A6  (Figure  6D–F)  revealed  an  interesting  distinction
between  pterygium  and  normal  cornea.  S100A9  was
detectable  in  regions  of  the  pterygium  body  and  in  the
pterygium/conjunctiva region, with no detectable labeling in
normal corneal epithelium (Figure 6A), consistent with EST
data. In contrast, S100A6 was detectable in normal corneal
epithelium but not in pterygium. This also corresponds to the
EST data; levels of abundance for S100A6 in the pterygium
and  BodyMap  cornea  libraries  were  0.04%  and  0.7%,
respectively. Although a recent study of S100 proteins in
pterygium and conjunctiva shows significant expression of
A6 and A9 in both tissues, the degree of difference between
pterygium  and  cornea  is  not  addressed  [61].  The  data
presented here suggest that S100A9 may be a pterygium and/
or conjunctiva marker.
Several other genes associated with cell migration or
neoplastic phenotypes are also represented by multiple clones
in the pterygium dataset. There are three clones for Jagged 1,
which is mutated in Alagille syndrome [62] and is a major
ligand  for  Notch  proteins.  Notch/Jagged  interaction  is
associated with tumorigenesis and proliferation and also with
epithelial-to-mesenchymal transition [63]. Tumor protein 63
(Tp63), a transcriptional regulator related to p53, is commonly
overexpressed in squamous carcinomas of epithelium [64]
and is represented by two clones. Tp63 has been shown to
regulate expression of several classes of genes involved in cell
migration, among them AQP3 [55], which has been shown to
be required for cell migration and proliferation during corneal
re-epithelialization  [65].  As  noted  above,  AQP3  itself  is
represented by five clones in the pterygium dataset.
Effect  of  modulation  of  SAT1  upon  migration  of
pterygium  primary  cultures:  The  relative  abundance  in
pterygium of transcripts for certain proteins associated with
cell migration suggests pathways that may be important in the
spread of pterygium. Targeted inhibition of some of these
proteins could therefore be useful in reducing the progression
of the growth. SAT1, which is among the most abundant
transcripts in pterygium and which, by immunofluorescence,
appears to be at higher levels in pterygium than in normal
cornea, is a potential target for such inhibition. In addition to
Figure 6. Immunfluorescence of SA100A9 and A6 shows differential expression in pterygium and normal cornea. S100A9 and S100A6
immunfluorescence are shown in red, and nuclei are DAPI labeled in blue. CE, corneal epithelium; Pt, pterygium; Cj, conjunctiva. Panels
A–C show results for S100A9, and panels D–F show results for S100A6. A: S100A9 in normal corneal epithelium. B: S100A9 in pterygium
body. C: S100A9 in pterygium/conjunctiva boundary. D: S100A6 in normal corneal epithelium. E: S100A6 in pterygium leading edge. F:
S100A6 in pterygium body. SA100A9 is clearly detectable in the conjunctiva and in the pterygium but is absent from normal corneal epithelium
while SA100A6 is most abundant in corneal epithelium and is at much lower levels in pterygium and conjunctiva.
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2429Figure 7. Effect of polyamine analogues
on  migration  of  primary  cultures  of
pterygium cells. Plots show the relative
migration of cells treated with either A:
BENSpm (no serum), B: IPENSpm (no
serum), or C: IPENSpm (5% serum).
Migration was assayed in terms of the
fluorescent signal at 480/520 nm. Error
bars indicate the standard error of the
mean. Each set of conditions was tested
a minimum of four times.
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2430its central role in many cellular processes through regulation
of polyamine levels and its complex patterns of upregulation
and downregulation in various disease states, SAT1 has also
been  shown  to  enhance  cell  migration  through  specific
binding  to  integrin α9  [ 20].  This  effect  requires  that  the
catalytic machinery of SAT1 be functional, suggesting local
effects on polyamines may be important modifiers of SAT1–
integrin-dependent  cell  migration.  Numerous  polyamine
analogues  have  been  developed,  particularly  for  use  as
antitumor agents. Several of these act as inhibitors of SAT1
activity  [66-68]  but  depending  on  the  particular  cell  type
involved may produce different results [69]. The analogue
BENSpm superinduces SAT1 [70,71], while other analogues,
such as IPENSpm, have only minor effects on SAT1 [72]. We
tested the effects of these two compounds on the migration of
cultured pterygium cells (Figure 7). In tests under serum-free
conditions  with  concentrations  up  to  10  μM,  BENSpm
produced an increase in migration (Figure 7A). In contrast,
over  a  similar  concentration  range,  IPENSpm  caused  a
significant  inhibition  of  cell  migration  (Figure  7B).  The
inhibitory effect of IPENSpm was also investigated in the
presence of 5% serum (Figure 7C). A significant reduction in
cell migration was again observed, with a maximum effect at
a  concentration  of  5μM.  Although  several  polyamine
analogues  (notably  BENSpm)  have  been  shown  to  have
cytotoxic effects on various tumor cell lines, neither drug had
any effect upon cultured pterygium cell viability when tested
at 10 µM concentrations (data not shown). Although a higher
concentration  (20  μM)  of  IPENSpm  was  also  tested  in
migration assays, the results were not substantially different
from  those  obtained  at  10  μM  concentrations;  thus  it  is
unlikely that toxicity played a role in migration results.
Conclusions: EST analysis of excised human pterygia
shows that differentiation markers for conjunctiva, limbus,
and cornea are present, with conjunctival and limbal markers
more abundantly expressed. This is illustrated by the higher
abundance of clones for Krt13/4 in pterygium compared with
the smaller number of clones for the corneal marker Krt12 and
the  absence  of  its  partner  Krt3.  Immunofluorescence
localization shows a mixed population of Krt13- and Krt12-
positive cells in the leading edge, supporting the paradigm of
pterygium as an invasion of the cornea by altered limbal cells,
followed by conjunctival cells [9]. At the same time that
conjunctival and limbal markers predominate, expression of
some  genes  characteristic  of  cornea  is  diminished  in  the
pterygium cDNA library. These include the cornea marker
ALDH3A1  and  the  SLRPs,  a  family  of  proteins  highly
expressed and functionally important in the cornea.
Pathway analysis calls attention to connections among
genes that are abundant in the pterygium cDNA dataset and
that  share  an  association  with  cell  migration.  Indeed,
immunofluorescence data are consistent with migration of
altered cells into the corneal epithelium. One of these genes,
SAT1, is a key regulator of polyamines, and one polyamine
analogue,  IPENSpm,  a  potential  inhibitor  of  SAT1,
significantly  reduces  migration  in  primary  cultures  of
pterygium. Inhibitors of cell migration, such as IPENSpm,
may provide new opportunities for therapeutic approaches to
block or reduce the spread of pterygium.
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